{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T16:40:27Z","timestamp":1758818427182},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Science Inc"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1007\/s11906-006-0070-3","type":"journal-article","created":{"date-parts":[[2007,5,24]],"date-time":"2007-05-24T20:11:57Z","timestamp":1180037517000},"page":"309-316","source":"Crossref","is-referenced-by-count":11,"title":["Genetic information in the diagnosis and treatment of hypertension"],"prefix":"10.1007","volume":"8","author":[{"given":"Maciej","family":"Tomaszewski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lukas","family":"Zimmerli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fadi J.","family":"Charchar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna F.","family":"Dominiczak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"70_CR1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1291\/hypres.27.193","volume":"27","author":"M Omura","year":"2004","unstructured":"Omura M, Saito J, Yamaguchi K, et al.: Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res 2004, 27:193\u2013202.","journal-title":"Hypertens Res"},{"key":"70_CR2","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/355262a0","volume":"355","author":"RP Lifton","year":"1992","unstructured":"Lifton RP, Dluhy RG, Powers M, et al.: A chimaeric 11 beta-hydroxylase\/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 1992, 355:262\u2013265.","journal-title":"Nature"},{"key":"70_CR3","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/00004872-200404000-00001","volume":"22","author":"P Mulatero","year":"2004","unstructured":"Mulatero P, Morello F, Veglio F: Genetics of primary aldosteronism. J Hypertens 2004, 22:663\u2013670.","journal-title":"J Hypertens"},{"key":"70_CR4","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1067\/mpd.2001.112648","volume":"138","author":"RG Dluhy","year":"2001","unstructured":"Dluhy RG, Anderson B, Harlin B, et al.: Glucocorticoid-remediable aldosteronism is associated with severe hypertension in early childhood. J Pediatr 2001, 138:715\u2013720.","journal-title":"J Pediatr"},{"key":"70_CR5","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0092-8674(01)00241-0","volume":"104","author":"R Lifton","year":"2001","unstructured":"Lifton R, Gharavi A, Geller D: Molecular mechanisms of human hypertension. Cell 2001, 104:545\u2013556.","journal-title":"Cell"},{"key":"70_CR6","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.tem.2005.02.011","volume":"16","author":"MI New","year":"2005","unstructured":"New MI, Geller DS, Fallo F, et al.: Monogenic low renin hypertension. Trends Endocrinol Metab 2005, 16:92\u201397. A topical, concise review on clinical aspects of monogenic hypertension.","journal-title":"Trends Endocrinol Metab"},{"key":"70_CR7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0960-0760(01)00097-8","volume":"78","author":"M Stowasser","year":"2001","unstructured":"Stowasser M, Gordon R: Familial hyperaldosteronism. J Steroid Biochem Mol Biol 2001, 78:215\u2013229.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"70_CR8","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.1210\/jcem.83.12.5309","volume":"83","author":"AA MacConnachie","year":"1998","unstructured":"MacConnachie AA, Kelly KF, McNamara A, et al.: Rapid diagnosis and identification of cross-over sites in patients with glucocorticoid remediable aldosteronism. J Clin Endocrinol Metab 1998, 83:4328\u20134331.","journal-title":"J Clin Endocrinol Metab"},{"key":"70_CR9","first-page":"329","volume":"46","author":"G Adler","year":"2005","unstructured":"Adler G, Widecka K, Peczkowska M, et al.: Genetic screening for glucocorticoid-remediable aldosteronism (GRA): experience of three clinical centres in Poland. J Appl Genet 2005, 46:329\u2013332.","journal-title":"J Appl Genet"},{"key":"70_CR10","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1210\/jc.2005-2708","volume":"91","author":"L Groussin","year":"2006","unstructured":"Groussin L, Horvath A, Jullian E, et al.: A PRKAR1A mutation associated with primary pigmented nodular adrenocortical disease in 12 kindreds. J Clin Endocrinol Metab 2006, 91:1943\u20131949. An excellent example of progress in cardiovascular genetics in uncovering mechanisms of endocrine diseases.","journal-title":"J Clin Endocrinol Metab"},{"key":"70_CR11","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1530\/eje.1.02004","volume":"153","author":"R Libe","year":"2005","unstructured":"Libe R, Bertherat J: Molecular genetics of adrenocortical tumours, from familial to sporadic diseases. Eur J Endocrinol 2005, 153:477\u2013487.","journal-title":"Eur J Endocrinol"},{"key":"70_CR12","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1210\/jc.2002-020592","volume":"87","author":"L Groussin","year":"2002","unstructured":"Groussin L, Jullian E, Perlemoine K, et al.: Mutations of the PRKAR1A gene in Cushing\u2019s syndrome due to sporadic primary pigmented nodular adrenocortical disease. J Clin Endocrinol Metab 2002, 87:4324\u20134329.","journal-title":"J Clin Endocrinol Metab"},{"key":"70_CR13","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/363458a0","volume":"363","author":"LM Mulligan","year":"1993","unstructured":"Mulligan LM, Kwok JB, Healey CS, et al.: Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 1993, 363:458\u2013460.","journal-title":"Nature"},{"key":"70_CR14","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/ng0194-70","volume":"6","author":"LM Mulligan","year":"1994","unstructured":"Mulligan LM, Eng C, Healey CS, et al.: Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN2A and FMTC. Nat Genet 1994, 6:70\u201374.","journal-title":"Nat Genet"},{"key":"70_CR15","unstructured":"Wiesner GL, Snow-Bailey K: Multiple endocrine neoplasia type 2. http:\/\/140.142.26.27\/servlet\/access?db=geneclinic s&site=gt&id=8888891&key=fkWDBgv-gytUT&gry=& fcn=y&fw=p6V2&.lename=\/profiles\/men2\/index.html. Accessed June 15, 2006. The most up-to-date information on genetic testing in patients with MEN2."},{"key":"70_CR16","first-page":"509","volume":"243","author":"M Takahashi","year":"1998","unstructured":"Takahashi M, Asai N, Iwashita T, et al.: Molecular mechanisms of development of multiple endocrine neoplasia 2 by RET mutations. J Intern Med 1998, 243:509\u2013513.","journal-title":"J Intern Med"},{"key":"70_CR17","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.8493574","volume":"260","author":"F Latif","year":"1993","unstructured":"Latif F, Tory K, Gnarra J, et al.: Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 1993, 260:1317\u20131320.","journal-title":"Science"},{"key":"70_CR18","unstructured":"Schimke RN, Collins DL, Stolle CA: Von Hippel-Lindau syndrome. http:\/\/140.142.26.27\/servlet\/access?db=genec linics&site=gt&id=8888892&key=rcP7MCsyeptb1&gry =&fcn=y&fw=HfTO&.lename=\/profiles\/vhl\/index.html. Accessed June 15, 2006. The most up-to-date information on genetic testing in patients with von Hippel-Lindau syndrome."},{"key":"70_CR19","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/(SICI)1098-1004(1998)12:6<417::AID-HUMU8>3.0.CO;2-K","volume":"12","author":"C Stolle","year":"1998","unstructured":"Stolle C, Glenn G, Zbar B, et al.: Improved detection of germline mutations in the von Hippel-Lindau disease tumour suppressor gene. Hum Mutat 1998, 12:417\u2013423.","journal-title":"Hum Mutat"},{"key":"70_CR20","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1200\/JCO.2003.03.189","volume":"21","author":"American Society of Clinical Oncology","year":"2003","unstructured":"American Society of Clinical Oncology: American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. J Clin Oncol 2003, 21:2397\u20132406.","journal-title":"J Clin Oncol"},{"key":"70_CR21","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/hmg\/9.2.237","volume":"9","author":"S Ars","year":"2000","unstructured":"Ars S, Serra E, Garcia J, et al.: Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1. Hum Mol Genet 2000, 9:237\u2013247.","journal-title":"Hum Mol Genet"},{"key":"70_CR22","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00467-003-1397-5","volume":"19","author":"G Lama","year":"2004","unstructured":"Lama G, Graziano L, Calabrese E, et al.: Blood pressure and cardiovascular involvement in children with neurofibromatosis type 1. Pediatr Nephrol 2004, 19:413\u2013418.","journal-title":"Pediatr Nephrol"},{"key":"70_CR23","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(05)67139-5","volume":"366","author":"JWM Lenders","year":"2005","unstructured":"Lenders JWM, Eisenhofer G, Mannelli M, et al.: Pheochromocytoma. Lancet 2005, 366:665\u2013675. A state-of-the-art review presenting current views on pathogenesis, diagnosis, and treatment of pheochromocytoma.","journal-title":"Lancet"},{"key":"70_CR24","unstructured":"Friedman JM. Neurofibromatosis 1. http:\/\/140.142.26.27\/ servlet\/access?db=geneclinics&site=gt&id=8888892&key =3t6-IckLoIkR3&gry=&fcn=y&fw=lXJ7&filename=\/profiles\/nf1\/index.html. Accessed June 15, 2006."},{"key":"70_CR25","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1136\/jmg.39.3.178","volume":"39","author":"BE Baysal","year":"2002","unstructured":"Baysal BE, Willett-Brozick JE, Lawrence EC, et al.: Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas. J Med Genet 2002, 39:178\u2013183.","journal-title":"J Med Genet"},{"key":"70_CR26","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jama.292.8.943","volume":"292","author":"HP Neumann","year":"2004","unstructured":"Neumann HP, Pawlu C, Peczkowska M, et al.: Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA 2004, 292:943\u2013951.","journal-title":"JAMA"},{"key":"70_CR27","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/ajmg.c.30018","volume":"129","author":"BE Baysal","year":"2004","unstructured":"Baysal BE: Genomic imprinting and environment in hereditary paraganglioma. Am J Med Genet C Semin Med Genet 2004, 129:85\u201390.","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"70_CR28","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1056\/NEJMoa020152","volume":"346","author":"HP Neumann","year":"2002","unstructured":"Neumann HP, Bausch B, McWhinney SR, et al.: Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 2002, 346:1459\u20131466.","journal-title":"N Engl J Med"},{"key":"70_CR29","doi-asserted-by":"crossref","first-page":"8812","DOI":"10.1200\/JCO.2005.03.1484","volume":"23","author":"L Amar","year":"2005","unstructured":"Amar L, Bertherat J, Baudin E, et al.: Genetic testing in pheochromocytoma or functional paraganglioma. J Clin Oncol 2005, 23:8812\u20138818.","journal-title":"J Clin Oncol"},{"key":"70_CR30","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1111\/j.1523-1755.2005.00711.x","volume":"68","author":"TI Steinman","year":"2005","unstructured":"Steinman TI: Polycystic kidney disease: a new perspective from the beginning. Kidney Int 2005, 68:2398\u20132399.","journal-title":"Kidney Int"},{"key":"70_CR31","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1111\/j.1523-1755.2005.00201.x","volume":"67","author":"AC Ong","year":"2005","unstructured":"Ong AC, Harris PC: Molecular pathogenesis of ADPKD: the polycystin complex gets complex. Kidney Int 2005, 67:1234\u20131247. An excellent summary of current knowledge about genetic and molecular mechanisms of ADPKD.","journal-title":"Kidney Int"},{"key":"70_CR32","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.amjhyper.2004.06.020","volume":"17","author":"CL Kelleher","year":"2004","unstructured":"Kelleher CL, McFann KK, Johnson AM, et al.: Characteristics of hypertension in young adults with autosomal dominant polycystic kidney disease compared with the general U.S. population. Am J Hypertens 2004, 17:1029\u20131034.","journal-title":"Am J Hypertens"},{"key":"70_CR33","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1681\/ASN.V881292","volume":"8","author":"AM Chapman","year":"1997","unstructured":"Chapman AM, Johnson S, Rainguet S, et al.: Left ventricular hypertrophy in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1997, 8:1292\u20131297.","journal-title":"J Am Soc Nephrol"},{"key":"70_CR34","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1093\/ndt\/15.9.1373","volume":"15","author":"C Nicolau","year":"2000","unstructured":"Nicolau C, Torra R, Badenas C, et al.: Sonographic pattern of recessive polycystic kidney disease in young adults. Differences from the dominant form. Nephrol Dial Transplant 2000, 15:1373\u20131378.","journal-title":"Nephrol Dial Transplant"},{"key":"70_CR35","first-page":"295","volume":"10","author":"A Sessa","year":"1997","unstructured":"Sessa A, Ghiggeri GM, Turco AE: Autosomal dominant polycystic kidney disease: clinical and genetic aspects. J Nephrol 1997, 10:295\u2013310.","journal-title":"J Nephrol"},{"key":"70_CR36","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1053\/j.ajkd.2005.07.016","volume":"46","author":"RD Perrone","year":"2005","unstructured":"Perrone RD, Miskulin DC:. Hypertension in individuals at risk for autosomal dominant polycystic kidney disease: to screen or not to screen. Am J Kidney Dis 2005, 46:557\u2013559. An excellent editorial containing critical evaluation of indications for genetic screening in ADPKD.","journal-title":"Am J Kidney Dis"},{"key":"70_CR37","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S1043-2760(03)00112-7","volume":"14","author":"M Stowasser","year":"2003","unstructured":"Stowasser M, Gordon RD: Primary aldosteronism: from genesis to genetics. Trends Endocrinol Metab 2003, 14:310\u2013317.","journal-title":"Trends Endocrinol Metab"},{"key":"70_CR38","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1056\/NEJMra035098","volume":"349","author":"EG Nabel","year":"2003","unstructured":"Nabel EG:. Cardiovascular disease. N Engl J Med 2003, 349:60\u201372. A very up-to-date review on molecular mechanisms underlying cardiovascular diseases.","journal-title":"N Engl J Med"},{"key":"70_CR39","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1097\/00004872-199715100-00007","volume":"15","author":"X Jeunemaitre","year":"1997","unstructured":"Jeunemaitre X, Bassilana F, Persu A, et al.: Genotype-phenotype analysis of a newly discovered family with Liddle\u2019s syndrome. J Hypertens 1997, 15:1091\u20131100.","journal-title":"J Hypertens"},{"key":"70_CR40","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1210\/jc.2004-1027","volume":"90","author":"M Furuhashi","year":"2005","unstructured":"Furuhashi M, Kitamura K, Adachi M, et al.: Liddle\u2019s syndrome caused by a novel mutation in the proline-rich PY motif of the epithelial sodium channel beta-subunit. J Clin Endocrinol Metab 2005, 90:340\u2013344.","journal-title":"J Clin Endocrinol Metab"},{"key":"70_CR41","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1161\/01.HYP.0000022570.02119.75","volume":"40","author":"EH Baker","year":"2002","unstructured":"Baker EH, Duggal A, Dong Y, et al.: Amiloride, a specific drug for hypertension in black people with T594M variant? Hypertension 2002, 40:13\u201317.","journal-title":"Hypertension"},{"key":"70_CR42","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1161\/01.HYP.0000200704.45994.ff","volume":"47","author":"JM Hollier","year":"2006","unstructured":"Hollier JM, Martin DF, Bell DM, et al.: Epithelial sodium channel allele T594M is not associated with blood pressure or blood pressure response to amiloride. Hypertension 2006, 47:428\u2013433.","journal-title":"Hypertension"},{"key":"70_CR43","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1126\/science.1062844","volume":"293","author":"FH Wilson","year":"2001","unstructured":"Wilson FH, Disse-Nicodeme S, Choate KA, et al.: Human hypertension caused by mutations in WNK kinases. Science 2001, 293:1107\u20131112.","journal-title":"Science"},{"key":"70_CR44","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1161\/CIRCULATIONAHA.105.585737","volume":"112","author":"H Zhang","year":"2005","unstructured":"Zhang H, Staessen JA: Association of blood pressure with genetic variation in WNK kinases in a white European population. Circulation 2005, 112:3371\u20133372.","journal-title":"Circulation"},{"key":"70_CR45","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1210\/jcem.87.7.8449","volume":"87","author":"H Mayan","year":"2002","unstructured":"Mayan H, Vered I, Mouallem M, et al.: Pseudohypoaldosteronism type II: marked sensitivity to thiazides, hypercalciuria, normomagnesemia, and low bone mineral density. J Clin Endocrinol Metab 2002, 87:3248\u20133254.","journal-title":"J Clin Endocrinol Metab"},{"key":"70_CR46","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1161\/CIRCULATIONAHA.105.555474","volume":"112","author":"MD Tobin","year":"2005","unstructured":"Tobin MD, Raleigh SM, Newhouse S, et al.: Association of WNK1 gene polymorphisms and haplotypes with ambulatory blood pressure in the general population. Circulation 2005, 112:3423\u20133429.","journal-title":"Circulation"},{"key":"70_CR47","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1161\/01.HYP.0000186240.81996.57","volume":"46","author":"ST Turner","year":"2005","unstructured":"Turner ST, Schwartz GL, Chapman AB, et al.: WNK1 kinase polymorphism and blood pressure response to a thiazide diuretic. Hypertension 2005, 46:758\u2013765.","journal-title":"Hypertension"},{"key":"70_CR48","first-page":"443","volume":"26","author":"L Kurland","year":"2005","unstructured":"Kurland L, Lind L, Melhus H: Using genotyping to predict responses to anti-hypertensive treatment. Trends Pharmacol Sci 2005, 26:443\u2013447. An interesting review that highlights current concepts and challenges of current hypertension pharmacogenetics.","journal-title":"Trends Pharmacol Sci"},{"key":"70_CR49","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00041552-200301000-00011","volume":"12","author":"PE Cadman","year":"2003","unstructured":"Cadman PE, O\u2019Connor DT: Pharmacogenomics of hypertension. Curr Opin Nephrol Hypertens 2003, 12:61\u201370.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"70_CR50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2005.10.011","volume":"527","author":"G Siest","year":"2005","unstructured":"Siest G, Marteau JB, Maumus S, et al.: Pharmacogenomics and cardiovascular drugs: need for integrated biological system with phenotypes and proteomic markers. Eur J Pharmacol 2005, 527:1\u201322.","journal-title":"Eur J Pharmacol"},{"key":"70_CR51","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/01213011-200505000-00003","volume":"15","author":"AH Maitland-van der Zee","year":"2005","unstructured":"Maitland-van der Zee AH, Turner ST, Schwartz GL, et al.: A multilocus approach to the antihypertensive pharmacogenetics of hydrochlorothiazide. Pharmacogenet Genomics 2005, 15:287\u201393.","journal-title":"Pharmacogenet Genomics"},{"key":"70_CR52","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.amjhyper.2005.02.012","volume":"18","author":"AH Maitland-van der Zee","year":"2005","unstructured":"Maitland-van der Zee AH, Turner ST, Schwartz GL, et al.: Demographic, environmental, and genetic predictors of metabolic side effects of hydrochlorothiazide treatment in hypertensive subjects. Am J Hypertens 2005, 18:1077\u20131083.","journal-title":"Am J Hypertens"},{"key":"70_CR53","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1161\/01.HYP.0000197947.62601.9d","volume":"47","author":"S Padmanabhan","year":"2006","unstructured":"Padmanabhan S, Wallace C, Munroe PB, et al.: Chromosome 2p shows significant linkage to antihypertensive response in the British Genetics of Hypertension Study. Hypertension 2006, 47:603\u2013608. One of the first examples of a successful pharmacogenomic approach in studies on hypertension.","journal-title":"Hypertension"}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-006-0070-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11906-006-0070-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-006-0070-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,14]],"date-time":"2021-08-14T04:59:44Z","timestamp":1628917184000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11906-006-0070-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["70"],"URL":"https:\/\/doi.org\/10.1007\/s11906-006-0070-3","relation":{},"ISSN":["1522-6417","1534-3111"],"issn-type":[{"value":"1522-6417","type":"print"},{"value":"1534-3111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}